Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
QIFENG
873169
5
LAISAI LASER
871263
US Stock MarketDetailed Quotes
SION Sionna Therapeutics
- 12.320
- -0.250-1.99%
Close May 9 16:00 ET
- 12.320
- 0.0000.00%
Post 16:00 ET
543.61MMarket Cap-8.81P/E (TTM)
13.070High12.069Low122.10KVolume12.890Open12.570Pre Close1.52MTurnover1.15%Turnover RatioLossP/E (Static)44.12MShares25.19052wk High-3.32P/B130.45MFloat Cap7.25552wk Low--Dividend TTM10.59MShs Float25.190Historical High--Div YieldTTM7.96%Amplitude7.255Historical Low12.463Avg Price1Lot Size
About Sionna Therapeutics Company
Sionna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in researching, developing and commercializing novel medicines for cystic fibrosis. It is focused on advancing a robust pipeline of small molecules and complementary CFTR modulators designed to deliver transformative clinical outcomes and improve the quality of life for individuals living with cystic fibrosis. The company was founded by Greg Hurlbut and Mark Munson in August 2019 and is headquartered in Waltham, MA.
Company Profile
SymbolSION
Company NameSionna Therapeutics
Listing DateFeb 7, 2025
Issue Price18.00
Founded2019
CEOMr. Michael Cloonan
MarketNASDAQ
Employees41
Fiscal Year Ends12-31
Address21 Hickory Drive,Suite 500
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-617-819-2020
Websitehttp://www.sionnatx.com
Company Executives
- Name
- Position
- Salary
- Michael Cloonan
- Chief Executive Officer, President and Director
- 3.73M
- Jennifer Fitzpatrick
- Chief Legal Officer
- --
- Elena H. Ridloff, C.F.A.
- Principal Accounting Officer, Chief Financial Officer and Head of Corporate Development
- 1.30M
- Dr. Charlotte McKee, M.D.
- Chief Medical Officer
- 1.28M
- Laurie D. Stelzer, M.B.A.
- Independent Director
- 339.00K
- Dr. Peter A. Thompson,M.D.,F.A.C.P.
- Independent Director
- --
- Dr. Marcella Kuhlman Ruddy, M.D.,M.S.
- Independent Director
- --
- Dr. Lucian Iancovici, M.D.
- Independent Director
- --
- Dr. Joshua Resnick, M.B.A.,M.D.
- Independent Director
- --
- Dr. Joanne Louise Viney, PhD
- Independent Director
- --
- Dr. H. Edward Fleming, Jr,M.D.
- Independent Director
- --
- Dr. Bruce Booth, D.Phil.
- Independent Director
- --
- Paul J. Clancy, M.B.A.
- Chairperson of the Board
- 344.29K
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now